Malignant Melanoma in Child with Xeroderma Pigmentosum: A Rare Case
Downloads
Background: Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by photosensitivity, cutaneous pigmentary changes, and malignant tumor development at an early age. The basic defect underlying the clinical manifestations is nucleotide excision repair defect, leading to defective repair of ultraviolet (UV)-induced DNA. XP patients who are younger than 20 years of age have more than 1000-fold increased risk of developing malignant neoplasms of the skin, which commonly include squamous cell carcinoma, basal cell carcinoma, fibrosarcoma, and malignant melanoma. Malignant melanoma arises in only about 3% of XP patients. Purpose: To report a case of malignant melanoma in a child with XP. Case: A 7-years-old girl presented with multiple hypopigmentation and hyperpigmentation macules since age of two, throughout the body, more on sun-exposed areas. The physical examination showed solitary tumor extensive ulcero- proliferative surface with areas of hemorrhage and blackish pigmentation on the vertex region. Histological examination revealed a feature of nodular malignant melanoma, and the condition became worse after she underwent two cycles of chemotherapy. Discussion: Despite the rare occurrence, the nodular type of malignant melanoma in XP patients is the most aggressive and responsible for the fatal condition. Conclusion: Early detection of XP is necessary due to its fast-growing nature and high metastatic possibility as well as mortality index.
Hasan S, Saeed S. Journal of pigmentary disorders xeroderma pigmentosum - a rare genodermatosis: overview of literature. Pigmentary disorder 2015; 2(12): 56-9.
Moriwaki S, Kanda F, Hayashi M, Yamashita D. Xeroderma pigmentosum clinical practice guidelines. J Dermatol 2017; 44(10): 1-22.
Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum - cutaneous, ocular and neurological abnormalities in 830 published cases. Arch Dermatol 2011; 123: 241-50.
Naik SM, Shenoy AM, Rajshekar AN. Cutaneous malignancies in xeroderma pigmentosum: earlier management improves survival. Indian J Otolaryngol Head Neck Surg 2017; 75(2): 186–7.
Sethi M, Lehmann AR, Fassihi H. Xeroderma pigmentosum: a multidisciplinary approach. EMJ Dermato 2013; 1: 54–63.
Sugasawa K. Xeroderma pigmentosum genes: functions inside and outside DNA repair. Carcinogenesis 2018; 29(3): 455–65.
Brooks BP, Thompson AH, Bishop RJ, Janine A, Khan SG, Ueda T, et al. Ocular manifestations of xeroderma pigmentosum: long term follow-up highlights the role of DNA repair in protection from sun damage. Ophtalmology 2013; 120(7): 1324–36.
Gharote MA, Panchal HP, Anand AS, Patel AP, Parikh SK, Khatwani I V. Case report basosquamous carcinoma in xeroderma pigmentosum - a unusual case report. VJIM 2015; 18(1): 58–63.
Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Porc Natl Acad Sci USA 2009; 106(15): 6279-84.
DiGiovanna JJ, Runger TM, Kraemer KH. Hereditary disorders of genome instability and DNA repair. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. (Eds). Fitzpatrick's Dermatology in general medicine. 9th ed, volume 1 Mcgraw Hill; 2019. p. 2343-54.
Victoria, Dinesh, Ravikala R. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum. J Cancer Res Ther 2011; 7(2): 205–8.
Chokry S, Pandey G, Bhattarai N. Myrid of histopathological features of malignancy in xeroderma pigmentosum. NepJOL 2016; 3(1): 472–5.
Bradford PT, Goldstein AM, Tamura D, Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum : long term follow-up characterises the role of DNA repair. J Med Genet 2011; 48 (3): 168-76.
Anand B, Kailasam S, Kumar PM, Srividhya K. Xeroderma pigmentosum: a rare case report with review of literature. J Indian Acad Oral Med Radiol 2012; 24(4): 334–7.
Naik SM, Shenoy AM, Rajshekar AN. Cutaneous Malignancies in xeroderma pigmentosum : earlier management improves survival. Indian J Otolaryngol Head Neck Surg 2013; 65(2): 162–7.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.